Drug delivery systems for differential release in combination therapy.
about
Advances and Challenges of Liposome Assisted Drug DeliveryHierarchical unilamellar vesicles of controlled compositional heterogeneityTowards nanomedicines of the future: Remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields.Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.Nanoscale delivery systems for multiple drug combinations in cancer.Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.Nanoparticle actuated hollow drug delivery vehicles.Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.Polymeric micelles for multidrug delivery and combination therapy.Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formationMultivesicular droplets: a cell model system to study compartmentalised biochemical reactions.Flavonoid-based pH-responsive hydrogels as carrier of unstable drugs in oxidative conditions.Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation.Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.Polymer nanoparticles based on pyrene-functionalized poly(acrylic acid) for controlled release under photo and pH stimulation.Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells.
P2860
Q26773160-B85918B8-26C0-45B2-BE02-0BF7086A2303Q28485251-6145FE84-FA5F-4230-8328-CBA3BC170CF4Q30746490-B2A20A6F-6FB2-41F1-8855-1D9FAE079D57Q37115994-AE2058CC-A867-444F-974E-6BE181DC1AC6Q37951607-462FE893-8C82-4EE4-9AD5-A782D5CE7ABDQ37955222-70D84FAD-43D9-439E-8921-6BDB56062D9EQ37970756-72AC5280-E1CF-495C-8469-0F1522D1B8D1Q38208617-D1BF8AF2-79BD-449A-A13E-3E773962DAEFQ38677767-0E19014D-F3D5-40EE-BFCB-DB5F8F245F48Q38836010-F03EDAD9-DEA4-4BD9-90A8-C5DA4A7CE4D6Q39367399-A16E420F-BD7A-41EB-A6C9-B7BDA2CC33E8Q40589508-827046B0-48DF-4979-BCAF-120041851987Q42251230-D1E3E3AE-568B-48F3-A2D9-52BAC5EBF843Q45387249-D3E8D7B5-8912-49B3-B588-AE09732CE068Q46448056-BF51E62F-E983-4E6E-BAFC-C8CEF024F5A7Q50047453-6A5C9D71-92DE-40CA-802D-BAFDDC0D6A67Q50479711-66F5D8F8-75DE-44D8-9400-DEB9EECD3C74Q55055773-BDA9371B-BCDC-4A90-B53C-A7C5E079B343
P2860
Drug delivery systems for differential release in combination therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug delivery systems for differential release in combination therapy.
@en
Drug delivery systems for differential release in combination therapy.
@nl
type
label
Drug delivery systems for differential release in combination therapy.
@en
Drug delivery systems for differential release in combination therapy.
@nl
prefLabel
Drug delivery systems for differential release in combination therapy.
@en
Drug delivery systems for differential release in combination therapy.
@nl
P2093
P2860
P1476
Drug delivery systems for differential release in combination therapy.
@en
P2093
Guojie Wang
Hongbin Zhang
P2860
P304
P356
10.1517/17425247.2011.547470
P407
P577
2011-01-13T00:00:00Z